Ossium Health is a bioengineering stem-cell research company. With a mission to treat diseases such as leukemia or radiation poisoning, Ossium Health uses its understanding of biology to improve the health and longevity of its patients. Additionally, the company has a specialization in Cryopreservation, bone marrow banking, stem cell transplants, and bone marrow transplants. Ossium Health was founded by Dr. Sebastian Eriksson Giwa, Erik Woods, and Kevin Caldwell in 2016 and is headquartered in San Francisco, CA.
Ossium Health is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Ossium Health pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Ossium Health is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
7/25/2023 | Series C | $50.72MM raised | $XXX.XX | $XXX.XX |
3/10/2021 | Series B, B Prime, B-1, B-1 Prime, B-2, B-2 Prime, B-3 and B-3 Prime | $63.43MM raised | $XXX.XX | $XXX.XX |
5/14/2018 | Series A, A Prime, A-1, A-1 Prime, A-2, A-2 Prime, A-3 and A-3 Prime | $10.72MM raised | $XXX.XX | $XXX.XX |